|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #Redirect[[Nephritic syndrome#Epidemiology and demographics]] |
| {{Nephritic syndrome}}
| |
| {{CMG}}; {{AE}} [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]]
| |
| | |
| ==Overview==
| |
| Approximately 25% of patients with acute [[glomerulonephritis]] present with nephritic syndrome. Acute glomerulonephritis accounts for 10-15% of [[glomerular]] diseases in the USA. The reported [[incidence]] of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1. The most common cause of glomerulonephritis worldwide is [[IgA nephropathy]] ([[Berger disease]]). Approximately 25-30% of patients eventually develop [[end-stage renal disease]] ([[ESRD]]). The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies. Additionally, the true incidence is difficult to predict because the disease might present subclinically.
| |
| ==Epidemiology and Demographics==
| |
| * Approximately 25% of patients with acute [[glomerulonephritis]] present with nephritic syndrome.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref>
| |
| * Acute glomerulonephritis accounts for 10-15% of [[glomerular]] diseases in the USA.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref>
| |
| * The reported [[incidence]] of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1.<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref>
| |
| * The most common cause of glomerulonephritis worldwide is [[IgA nephropathy]] ([[Berger disease]]). Approximately 25-30% of patients eventually develop [[end-stage renal disease]] ([[ESRD]]).<ref name="pmid21068142" />
| |
| * he yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.<ref name="pmid21068142" />
| |
| * The true incidence is difficult to predict because the disease might present subclinically.
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| {{WH}}
| |
| {{WS}}
| |
| [[Category:Needs content]]
| |
| [[Category:Disease]]
| |
| [[Category:Nephrology]]
| |
| [[Category:Syndromes]]
| |
| [[Category:Pediatrics]]
| |